Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-054568
Filing Date
2023-05-01
Accepted
2023-05-01 17:28:42
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tm2314306d1_10ka.htm   iXBRL 10-K/A 357792
2 EXHIBIT 31.3 tm2314306d1_ex31-3.htm EX-31.3 3961
3 EXHIBIT 31.4 tm2314306d1_ex31-4.htm EX-31.4 3893
  Complete submission text file 0001104659-23-054568.txt   663775

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20221231.xsd EX-101.SCH 4105
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gdnsf-20221231_def.xml EX-101.DEF 27933
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20221231_lab.xml EX-101.LAB 38476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20221231_pre.xml EX-101.PRE 26544
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2314306d1_10ka_htm.xml XML 6952
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56225 | Film No.: 23875367
SIC: 2834 Pharmaceutical Preparations